CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation)

The goal of this clinical trial is to learn if selectively omitting postoperative cervical irradiation is a safe and feasible treatment strategy for patients with resected, locally advanced squamous cell carcinoma of the head and neck (HNSCC) who underwent systematic neck dissection and have no high-risk nodal factors. The main questions it aims to answer are: * Is the regional recurrence rate with selective omission of postoperative cervical irradiation non-inferior to the recurrence rate reported with standard complete nodal irradiation (6-8%)? * Does selective omission of postoperative cer

Trial Details

NCT ID
NCT07755449
Phase
PHASE2
Sponsor
Institut Català d'Oncologia
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • IMRT OR VMAT Radiotherapy excluding cervical radiation
Locations (sample)
  • L'Hospitalet de Llobregat, Barcelona, Spain|41.35967,2.10028

Key Eligibility Criteria

  • Patients ≥ 18 years of age
  • ECOG Performance Status (PS) ≤ 2
  • Histologically confirmed diagnosis of locally advanced squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx
  • Resection of the primary tumor and unilateral and/or bilateral neck dissection performed according to standard guidelines, with detailed histologic…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →